For adults with Fabry disease
Elfabrio is an enzyme replacement therapy (ERT) that has been shown to work safely and effectively over the long term in adults with Fabry disease.† And with a long half-life, Elfabrio can last for a long time in your body.
|*||Elfabrio has an initial half-life of 78.9 ± 10.3 hours. Clinical studies have not shown that a long half-life results in a medicine working better or more safely. Infusions are every 2 weeks.|
|†||Trials within the Full Prescribing Information extend up to 2 years.|
|‡||The initial 4-6 infusions are no less than 3-4 hours. Maintenance infusions are as short as 1.5 hours.|